Structural and Functional Analysis of Olmesartan As an Inverse Agonist for Angiotensin Ii Type 1 Receptor

Noritaka Yasuda,Hiroshi Akazawa,Yingjie Qin,Zhi Li,Yunzeng Zou,Issei Komuro

DOI: https://doi.org/10.1016/j.yjmcc.2007.03.084

IF: 5.763

2007-01-01

Journal of Molecular and Cellular Cardiology

Abstract:Recently, we have demonstrated that AT1 receptor can be activated by mechanical stress through an Ang II-independent mechanism and that this activation is inhibited by an inverse agonist of AT1 receptor. In this study, we analyzed the molecular basis of olmesartan, a potent inverse agonist of AT1 receptor. Olmesartan has a unique carboxyl group and a hydroxyl group on the imidazole ring. We compared inverse agonist activities of olmesartan with its derivative RNH8282 and RNH6384, in which the carboxyl group or hydroxyl group was deleted, respectively. Activations of ERKs by stretch were strongly inhibited by olmesartan, but not by RNH8282 or RNH6384 in cultured cardiomyocytes and HEK293 cells expressing AT1 receptor. Overexpression of constitutively activated AT1 (N111G mutant) enhanced the promoter activities of c-fos gene, and this activation was strongly attenuated by olmesartan but marginally by RNH8282 or RNH6384. Interestingly, a 100-fold higher concentration of RNH8282 or 10-fold higher concentration of RNH6384 inhibited Ang II-induced ERKs activation and c-fos promotor activation to the similar degree with olmesartan but did not inhibit stretch-induced ERKs activation or constitutively activated AT1 induced c-fos promotor activation. These results suggest that the carboxyl group together with the hydroxyl group contribute to the potent inverse agonist activity of olmesartan.